Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma

Andrew G. Winer, Emily A. Vertosick, Mazyar Ghanaat, Renato B. Corradi, Sigrid Carlsson, Daniel D. Sjoberg, Alexander I. Sankin, John P. Sfakianos, Eugene K. Cha, Guido Dalbagni, Jonathan A. Coleman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: Lymph node dissection (LND) performed during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) remains controversial and difficult to evaluate. The aim of this study was to investigate whether removal of more lymph nodes during RNU is safe and improves oncologic outcomes. Methods: We evaluated 422 patients who underwent RNU with concomitant LND for upper tract urothelial carcinoma between 1976 and 2015, assessing for an association between total nodes removed, recurrence-free survival, and cancer-specific survival using Cox proportional hazards models. We also investigated the relationship between nodal yield and perioperative metrics and intersurgeon variability using linear regression. Results: In our cohort of 442 patients, 239 developed recurrences and 94 patients died of disease. Median follow-up among survivors was 3.7 years (interquartile range: 1.2, 7.4). The median nodal yield was 9 (interquartile range: 4, 16). Among patients with node-positive disease (pN1), we observed a significant improvement in recurrence-free survival (hazard ratio = 0.84 per 5 nodes removed, . P = 0.039) and a nonsignificant improvement in cancer-specific survival with an increase in the nodal yield (hazard ratio = 0.90 per 5 nodes removed, . P = 0.2). There was no evidence of an association between node yield and operative time, estimated blood loss, or 30-day complications on multivariable analysis. There was significant heterogeneity among surgeons regarding the extent of LND (P<0.0001). Conclusions: We found that a more extensive node dissection may improve oncologic outcomes in a subset of high-risk patients without significantly increasing operative time or serious complications. Additionally, we identified considerable intersurgeon heterogeneity regarding the extent of LND furthering the notion of surgeon variability as a nonstandardized factor.

Original languageEnglish (US)
JournalUrologic Oncology: Seminars and Original Investigations
DOIs
StateAccepted/In press - Jun 3 2016

Fingerprint

Lymph Node Excision
Lymph Nodes
Carcinoma
Survival
Operative Time
Recurrence
Proportional Hazards Models
Survivors
Dissection
Linear Models
Neoplasms
Surgeons

Keywords

  • Complications
  • Extent of lymph node dissection
  • Oncologic outcomes
  • Upper tract urothelial carcinoma
  • UTUC

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Winer, A. G., Vertosick, E. A., Ghanaat, M., Corradi, R. B., Carlsson, S., Sjoberg, D. D., ... Coleman, J. A. (Accepted/In press). Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2016.11.002

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. / Winer, Andrew G.; Vertosick, Emily A.; Ghanaat, Mazyar; Corradi, Renato B.; Carlsson, Sigrid; Sjoberg, Daniel D.; Sankin, Alexander I.; Sfakianos, John P.; Cha, Eugene K.; Dalbagni, Guido; Coleman, Jonathan A.

In: Urologic Oncology: Seminars and Original Investigations, 03.06.2016.

Research output: Contribution to journalArticle

Winer, Andrew G. ; Vertosick, Emily A. ; Ghanaat, Mazyar ; Corradi, Renato B. ; Carlsson, Sigrid ; Sjoberg, Daniel D. ; Sankin, Alexander I. ; Sfakianos, John P. ; Cha, Eugene K. ; Dalbagni, Guido ; Coleman, Jonathan A. / Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. In: Urologic Oncology: Seminars and Original Investigations. 2016.
@article{1110413ae16c4961862c40aa977d501a,
title = "Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma",
abstract = "Introduction: Lymph node dissection (LND) performed during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) remains controversial and difficult to evaluate. The aim of this study was to investigate whether removal of more lymph nodes during RNU is safe and improves oncologic outcomes. Methods: We evaluated 422 patients who underwent RNU with concomitant LND for upper tract urothelial carcinoma between 1976 and 2015, assessing for an association between total nodes removed, recurrence-free survival, and cancer-specific survival using Cox proportional hazards models. We also investigated the relationship between nodal yield and perioperative metrics and intersurgeon variability using linear regression. Results: In our cohort of 442 patients, 239 developed recurrences and 94 patients died of disease. Median follow-up among survivors was 3.7 years (interquartile range: 1.2, 7.4). The median nodal yield was 9 (interquartile range: 4, 16). Among patients with node-positive disease (pN1), we observed a significant improvement in recurrence-free survival (hazard ratio = 0.84 per 5 nodes removed, . P = 0.039) and a nonsignificant improvement in cancer-specific survival with an increase in the nodal yield (hazard ratio = 0.90 per 5 nodes removed, . P = 0.2). There was no evidence of an association between node yield and operative time, estimated blood loss, or 30-day complications on multivariable analysis. There was significant heterogeneity among surgeons regarding the extent of LND (P<0.0001). Conclusions: We found that a more extensive node dissection may improve oncologic outcomes in a subset of high-risk patients without significantly increasing operative time or serious complications. Additionally, we identified considerable intersurgeon heterogeneity regarding the extent of LND furthering the notion of surgeon variability as a nonstandardized factor.",
keywords = "Complications, Extent of lymph node dissection, Oncologic outcomes, Upper tract urothelial carcinoma, UTUC",
author = "Winer, {Andrew G.} and Vertosick, {Emily A.} and Mazyar Ghanaat and Corradi, {Renato B.} and Sigrid Carlsson and Sjoberg, {Daniel D.} and Sankin, {Alexander I.} and Sfakianos, {John P.} and Cha, {Eugene K.} and Guido Dalbagni and Coleman, {Jonathan A.}",
year = "2016",
month = "6",
day = "3",
doi = "10.1016/j.urolonc.2016.11.002",
language = "English (US)",
journal = "Urologic Oncology: Seminars and Original Investigations",
issn = "1078-1439",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma

AU - Winer, Andrew G.

AU - Vertosick, Emily A.

AU - Ghanaat, Mazyar

AU - Corradi, Renato B.

AU - Carlsson, Sigrid

AU - Sjoberg, Daniel D.

AU - Sankin, Alexander I.

AU - Sfakianos, John P.

AU - Cha, Eugene K.

AU - Dalbagni, Guido

AU - Coleman, Jonathan A.

PY - 2016/6/3

Y1 - 2016/6/3

N2 - Introduction: Lymph node dissection (LND) performed during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) remains controversial and difficult to evaluate. The aim of this study was to investigate whether removal of more lymph nodes during RNU is safe and improves oncologic outcomes. Methods: We evaluated 422 patients who underwent RNU with concomitant LND for upper tract urothelial carcinoma between 1976 and 2015, assessing for an association between total nodes removed, recurrence-free survival, and cancer-specific survival using Cox proportional hazards models. We also investigated the relationship between nodal yield and perioperative metrics and intersurgeon variability using linear regression. Results: In our cohort of 442 patients, 239 developed recurrences and 94 patients died of disease. Median follow-up among survivors was 3.7 years (interquartile range: 1.2, 7.4). The median nodal yield was 9 (interquartile range: 4, 16). Among patients with node-positive disease (pN1), we observed a significant improvement in recurrence-free survival (hazard ratio = 0.84 per 5 nodes removed, . P = 0.039) and a nonsignificant improvement in cancer-specific survival with an increase in the nodal yield (hazard ratio = 0.90 per 5 nodes removed, . P = 0.2). There was no evidence of an association between node yield and operative time, estimated blood loss, or 30-day complications on multivariable analysis. There was significant heterogeneity among surgeons regarding the extent of LND (P<0.0001). Conclusions: We found that a more extensive node dissection may improve oncologic outcomes in a subset of high-risk patients without significantly increasing operative time or serious complications. Additionally, we identified considerable intersurgeon heterogeneity regarding the extent of LND furthering the notion of surgeon variability as a nonstandardized factor.

AB - Introduction: Lymph node dissection (LND) performed during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) remains controversial and difficult to evaluate. The aim of this study was to investigate whether removal of more lymph nodes during RNU is safe and improves oncologic outcomes. Methods: We evaluated 422 patients who underwent RNU with concomitant LND for upper tract urothelial carcinoma between 1976 and 2015, assessing for an association between total nodes removed, recurrence-free survival, and cancer-specific survival using Cox proportional hazards models. We also investigated the relationship between nodal yield and perioperative metrics and intersurgeon variability using linear regression. Results: In our cohort of 442 patients, 239 developed recurrences and 94 patients died of disease. Median follow-up among survivors was 3.7 years (interquartile range: 1.2, 7.4). The median nodal yield was 9 (interquartile range: 4, 16). Among patients with node-positive disease (pN1), we observed a significant improvement in recurrence-free survival (hazard ratio = 0.84 per 5 nodes removed, . P = 0.039) and a nonsignificant improvement in cancer-specific survival with an increase in the nodal yield (hazard ratio = 0.90 per 5 nodes removed, . P = 0.2). There was no evidence of an association between node yield and operative time, estimated blood loss, or 30-day complications on multivariable analysis. There was significant heterogeneity among surgeons regarding the extent of LND (P<0.0001). Conclusions: We found that a more extensive node dissection may improve oncologic outcomes in a subset of high-risk patients without significantly increasing operative time or serious complications. Additionally, we identified considerable intersurgeon heterogeneity regarding the extent of LND furthering the notion of surgeon variability as a nonstandardized factor.

KW - Complications

KW - Extent of lymph node dissection

KW - Oncologic outcomes

KW - Upper tract urothelial carcinoma

KW - UTUC

UR - http://www.scopus.com/inward/record.url?scp=85007490606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007490606&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2016.11.002

DO - 10.1016/j.urolonc.2016.11.002

M3 - Article

C2 - 27932270

AN - SCOPUS:85007490606

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

SN - 1078-1439

ER -